South Korea Non-Hodgkins Lymphoma Market Analysis


  • Type: Oncology area
  • Published : June 2021
  • Region: Asia
  • Country: South Korea
  • Report ID : 4934

  • Format: PPT, PDF

South Korea Non-Hodgkin’s Lymphoma Market: Segmented By Type (B-Cell Lymphoma, T-Cell Lymphoma) and By Therapy (Targeted Therapy, Radiation Therapy, Chemotherapy and Others) – Growth, Trends and Forecasts (2019 – 2028)

SKU: 4934 Categories: ,

Report Overview

The South Korea Non-Hodgkin’s Lymphoma market size stood at around USD xx billion in 2020 and is projected to reach xx billion by 2028, exhibiting a CAGR of around 6.2% during the forecast period.

Non-Hodgkin’s lymphoma is a type of cancer that begins in lymphatic system, which is part of the body’s immune system. In non-Hodgkin’s lymphoma, white blood cells called lymphocytes grow abnormally and can form growths (tumours) throughout the body. Non-Hodgkin’s lymphoma is a general category of lymphoma. There are many subtypes that fall in this category. Diffuse large B-cell lymphoma and follicular lymphoma are among the most common subtypes.

According to GLOBOCAN report South Korea reported 5,431 new cases of Non-Hodgkin’s Lymphoma in 2020 and ranked eleventh among other cancer sites. It had the 8th highest death rate with 2,320 death in year 2020 (death rate 2.6%). The five-year prevalence rate was 25.77 per 100,000.

Market Drivers

Rise in the prevalence of Non-Hodgkin’s Lymphoma, demand for innovative drugs and novel technologies, and an increase in the number of FDA approvals for Non-Hodgkin’s Lymphoma therapy drugs are the factors, that are propelling the market growth. Furthermore, an increase in public awareness about Non-Hodgkin’s Lymphoma, strong drug pipeline for the treatment of the disease, improved diagnostic techniques are the factors fuelling the market growth.

However, the high cost of drugs and various complications associated with them are acting as major restraints for the Non-Hodgkin lymphoma market.


1. South Korea Non-Hodgkin’s Lymphoma Market Overview…………………
A. Market Size
2. Market Growth Drivers………………………….
A. Demand For Innovative Drugs And Novel Technologies
B. Robust Drug Pipelines
C. Increase In Prevalence Of Non-Hodgkin’s Lymphoma
3. Sub Types of Non-Hodgkin’s Lymphoma………………………………………..
A. Incidence Chronic Lymphocytic Leukaemia
B. Cutaneous B-Cell Lymphoma
C. Cutaneous T-Cell Lymphoma
D. Follicular Lymphoma
E. Waldenstrom Macroglobulinemia
4. Non-Hodgkin’s Lymphoma Market Segmentation……………………
A. Type
I. B-Cell Lymphoma
II. T-Cell Lymphoma
B. Therapy
I. Targeted Therapy
II. Radiation Therapy
III. Chemotherapy
IV. Others
5. Non-Hodgkin’s Lymphoma Market Share………………………………………
A. Market Analysis, Insights and Forecast – By Revenue
6. Competitive Landscape……………………………………………
A. Major Players
B. Products in Pipeline
7. Key Company Profiles………………………………………….
A. Boryung Pharmaceuticals Company Overview, Product & Services, Strategies & Financials
B. Celltrion Company Overview, Product & Services, Strategies & Financials
C. AstraZeneca Korea Company Overview, Product & Services, Strategies & Financials
8. Healthcare Policies and Regulatory Landscape……………………………
A. Policy changes and Reimbursement scenario
9. Factors Driving Future Growth……………………………………………
A. New Trends and Development of Non-Hodgkin’s Lymphoma Market
B. Future Opportunities
10. Conclusion

Market Segmentation

By Type:

On the basis of type Non-Hodgkin’s lymphoma market segments are B-cell lymphoma and T-Cell lymphoma.

B-cell non-Hodgkin lymphoma (BNHL) comprises a heterogeneous group of lymphoid malignancies that differ in their clinical presentation and progression. The most common type of mature BNHL in adults is diffuse large B-cell lymphoma (DLBCL), which comprises approximately 46% of mature BNHL in Korea. The prognosis of BNHL has improved in the last decade, attributed primarily to the addition of rituximab to standard chemotherapy regimens.

By Therapy:

According to therapy, liver cancer market segments are targeted therapy, radiation therapy, chemotherapy, and others.


Top Players

Domestic companies are performing well in the Non-Hodgkin’s lymphoma market and competing with the affluent global players. For instance, Truxima™ (rituximab) was the first biosimilar monoclonal antibody (mAb) approved for the treatment of haematological cancers, including diffuse large B-cell lymphoma, follicular lymphoma, and others. The drug was discovered and developed by Celltrion Healthcare; a company based in South Korea. Truxima™ received marketing approval from the Ministry of Food and Drug Safety in South Korea in November 2016.

In 2020, Celltrion also gained approval to launch its autoimmune disease drug Remsima which is a biosimilar of Janssen Biotech’s Remicade (infliximab). Remsima is currently in phase three clinical trial in the United States. Celltrion aims to complete the trial by 2021 and launch the drug in 2022.

Boryung Pharmaceutical Korea announced its approval for Phase 1 clinical studies on its anti-cancer therapy “BR2002” from the U.S. Food and Drug Administration (FDA) in 2019. It is due to be completed in February 2024. BR2002 represents the company’s efforts to push into the global anti-cancer treatment market.

Research Methodology

Insights10 will provide you reports within 10 key parameters which are:

  1. Market overview
  2. Market growth drivers & restraints
  3. Epidemiology or disease type
  4. Market segmentation
  5. Market share
  6. Competitive landscape
  7. Key company profiles
  8. Healthcare policies & regulatory framework
  9. Reimbursement scenario
  10. Factors driving future growth

Based on our many years of experience, we believe that these are the parameters that are critical to decision making for business stakeholders. Our focused approach to develop reports focused on 10 key parameters, enabled us to arrive at the name “Insights10”.

Our analysis methodology involves three critical stages:

Stage I: Market Data Collection

Primary Interviews: We have developed a network of experts, freelancers and researchers across countries through which we engage with local experts to gather key data points and assumptions around each market. We also engage regularly with some of the best market research agencies such as Atheneum, GuidePoint, GLG, etc. to conduct surveys and interviews, and build intelligence. We have language translators as a part of our team, who between them can cover 30+ languages allowing us to extract better local insights.

Secondary Data Collection: We have developed strong expertise and experience in secondary data collection methods for developing unique data sets and research material. We gather data from multiple reliable sources to maintain the high level of accuracy and consistency. The market data is analysed and forecasted using appropriate statistical and coherent models. The report offers an overall analysis of the market size, growth, market share as well as segment-level analysis of the specific market. Our report includes precise, to the point information related to the overall market, competition, growth drivers, challenges, regulatory updates, and competition.

Data Sources: We have access to multiple highly reliable free and subscription data sources. We have many years of experience to understand which sources are more dependable for what and which to prefer for the reliable and latest information. The key sources of information include the following, but are not limited to:

  • Statistical Databases
  • Company Websites/Annual Reports
  • Trade Publications
  • Online Databases
  • Published Research Reports
  • Whitepapers
  • Press Releases of Key Market Players

Stage II: Market Data Analysis and Statistical Model

Market Trends: We generally look at macro parameter and micro indicators. The macro parameters includes changes in government policies, demand and supply of the market, government intervention programs and major market share. The micro indicators GDP growth, market size, market volume etc. We also understand nuances specific to each country like US, Canada, India, Germany, etc. and have worked across 60+ countries and hence no only understand global trends, but how these differ by country, how payment models, market structure, cultural parameters, etc. differ in each country.

Market Sizing and Analysis: Our expert data analytics team has created various market forecast models by employing the top-down approach i.e. start with large overall market and segment different areas and bottom-up approach i.e. start with population and epidemiology and roll up based on spend, etc., estimating the size of the market, and distributing among the geographic and/or product segments.

The top-down approach mainly used for new product forecasting and bottom-up approach is used for demand estimation of any product for different countries summed up to form total market. We are able to round off insights and build stronger forecasts because we always do both these methods and triangulate the final numbers.

The study on the market covers the analysis of the leading geographies such as North America, Europe, Asia-Pacific, and Africa for the period of 2020 to 2028. The qualitative analysis covers the industry landscape and trends, market opportunities, competitive landscape and policy and regulatory scenario and the quantitative analysis covers different market estimates and forecasts.

Data Triangulation & Validation:

Data triangulation of various sources and results of the research are carried out by benchmarking with reliable sources such as industry statistics, statistical databases and the company level averages etc.

We make sure to finalize the numbers in alignment to the market research. Firstly, our internal experts ensure thorough validation and checking to ensure the accurate and precise analysis and then validation is also done using multiple data analysis model.  Two level validation is done and entails finalization of report scope and to way of representation pattern.

Stage III: Interpretation and Presentation

Analysis & Interpretation: The information gathered is then analysed and synthesized. A second series of interviews are done if necessary to check and validate. The future opportunities are analysed by understanding product commercialization and many other factors. It also comprises the analysis of data discrepancies observed across various data sources. Information procured from secondary and primary results are then, interpreted by considering following parameters: (a partial list)

  • Establishing market drivers and trends
  • Analyzing regulatory landscape to understand future growth
  • Market Segment based analysis to obtain revenue / volume
  • Analyzing current needs and determining penetration to estimate market

Insights: Our reports deliver actionable insights backed with supporting facts and figures to assist you in achieving exemplary growth. Our in-depth analyses are interspersed with relevant insights and statistics to offer an executive-level view of a given market. The description helps in correlating many minor factors affecting the market and its impact to the different segments within the market.
Data curated from the analysis and interpretation are drawn to portray all in one consolidated report.

Presentation & Reporting: The market research report is presented in different forms such as charts by using a scientific approach for easy understanding. Historic, current and future analysis is provided for each market in terms of both value and volume. The size of the market is interpreted in the US Dollar value and the respective unit, based on the product, for volume consumptions.
The foreign exchange rates are calculated on the respective dates and for the respective regions covered in the study.

To request a free sample copy this report, please complete the form below.

    We value your inquiry and offer free customization with every report to fulfil your exact research needs.

    This website is secure and your personal details are safe.

    This report addresses

    • Market intelligence to enable effective decision making
    • Growth opportunities and trend analysis
    • Competitive benchmarking
    • Historical data & forecasts
    • Regional opportunities

    Need more?

    • Speak to our analyst to know how this research was put together
    • Add more countries or regions as part of customisation
    • Understand how this report can have direct impact on your revenue

    Get a custom report based on your requirements